Effect of pre-transplant anaemia on perioperative cardiovascular morbidity and graft function in renal transplant patients

Introduction: Anaemia is a known complication of end stage renal disease (ESRD). The Kidney Disease: Improving Global Outcome (KDIGO) guidelines recommend that haemoglobin (Hb) level in patients with ESRD should be maintained at 11-11.5 g/dl. However, it is difficult to achieve these figures in under resourced countries with limited setup where patients with ESRD frequently run low haemoglobin concentrations.